Trump reclassifies cannabis in the US in ‘global validation moment’ for the plant’s medical potential by Steve Jones December 19, 2025February 21, 2026 Cannabis will finally be reclassified as a schedule III drug in the US in what is […]
Epsilon Healthcare resumes trading on ASX after two-year suspension by Steve Jones December 19, 2025December 22, 2025
Three cannabis firms fined by ODC for alleged licence breaches by Steve Jones December 19, 2025December 22, 2025
Savage Cabbage founder wins unfair dismissal case against Cannim subsidiary by Steve Jones December 18, 2025December 22, 2025
Chemist Warehouse deal ‘won’t change who we are’, Astrid founder insists as dispensary prepares for national expansion by Steve Jones December 18, 2025December 22, 2025
UIC conference returns with expanded program and discounts for Cannabiz members by Adam Sheldon December 17, 2025February 21, 2026
M&A ‘so hard’ in cannabis ‘as not much worth buying’, says Medcan boss by Steve Jones December 17, 2025December 18, 2025
News in brief: ECS explores US move; Epsilon reports half-year results by Steve Jones December 16, 2025February 21, 2026
‘A massive milestone and a huge relief’: Cannaponics finally receives permit to start growing by Steve Jones December 16, 2025December 16, 2025
